Clinical practice : diagnosis and treatment of functional constipation

Merit M Tabbers1, Nicole Boluyt, Marjolein Y Berger

  • 1Department of Paediatric Gastroenterology and Nutrition, Emma Children's Hospital/Academic Medical Centre, H7-250, PO Box 22700, 1100 DD, Amsterdam, the Netherlands. m.m.tabbers@amc.nl

Insights

Childhood functional constipation, a common pediatric issue, requires diagnosis via medical history and physical exam. Treatment follows a four-step approach, with guidelines recommending specific laxatives like lactulose or polyethylene glycol (PEG) based on age.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Practice Guidelines
  • Child Health

Background:

  • Childhood functional constipation affects 3% of Western children, presenting as infrequent, painful defecation, fecal incontinence, and abdominal pain.
  • Less than 5% of pediatric constipation cases stem from an underlying disease, highlighting the prevalence of functional causes.

Purpose of the Study:

  • To discuss recently developed evidence-based guidelines for the diagnosis and treatment of childhood functional constipation.
  • To compare recommendations from Dutch and Great Britain guidelines.

Main Methods:

  • Review and synthesis of two recent evidence-based guidelines for childhood constipation.
  • Analysis of diagnostic criteria and therapeutic approaches outlined in the guidelines.

Main Results:

  • Diagnosis of functional constipation is typically confirmed through a thorough medical history and physical examination.
  • Treatment involves a four-step process: education, disimpaction, prevention of fecal re-accumulation, and follow-up.
  • Limited evidence supports laxative superiority over placebo; however, guidelines recommend lactulose for infants under 1 year, and lactulose or polyethylene glycol (PEG) for older children, with PEG plus electrolytes favored by the NICE guideline for all ages.

Conclusions:

  • Children with functional constipation should be diagnosed and managed based on current evidence-based guidelines.
  • Adherence to these guidelines ensures appropriate and effective care for pediatric constipation.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...